SCHEMBL4747145

SCHEMBL4747145

O=c1nc2n(-c3ccc(F)cc3)c3cc(Cl)ccc3nc-2c(=O)[nH]1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GSR P00390 5/20 0.55
TDP2 O95551 7/20 0.52
MDM2 Q00987 4/20 0.42
MEN1 O00255 1/20 0.41
NGF P01138 1/20 0.41
NTRK1 P04629 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
TP53 P04637 2/20 0.41
NSD2 O96028 1/20 0.38
CASP3 P42574 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4747762 0.85 TDP2 (0.49) GSRTDP2MDM2MEN1NGF
SCHEMBL4748228 0.85 TDP2 (0.49) GSRTDP2MEN1NGFNTRK1
SCHEMBL4744197 0.84 TDP2 (0.48) GSRTDP2MDM2MEN1NGF
SCHEMBL4747662 0.83 HRH4 (0.47) GSRTDP2MEN1NGFNTRK1
SCHEMBL4748217 0.80 TDP2 (0.62) GSRTDP2MEN1NGFNTRK1
SCHEMBL9635797 0.72 GSR (0.70) GSRTDP2MEN1RECQLKMT2A
SCHEMBL17582837 0.72 GSR (0.45) GSRMAPT
SCHEMBL4746265 0.71 GSR (0.61) GSR
SCHEMBL4747745 0.69 MEN1 (0.48) GSRTDP2MEN1NGFNTRK1
SCHEMBL5047468 0.68 GSR (0.60) GSRTDP2MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008114009-A1 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CAMBRIDGE ENTERPRISE LTD. (GB) 2008-09-25 WO disclosed
WO-2008114009-A1 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CAMBRIDGE ENTERPRISE LTD. (GB) 2008-09-25 WO disclosed